D.A. Davidson analyst D.A. Davidson maintained a Hold rating on Prestige Brand Holdings (NYSE:PBH) on Friday, setting a price target of $52, which is approximately 4.27% above the present share price of $49.87.
expects Prestige Brand Holdings to post earnings per share (EPS) of $0.71 for the second quarter of 2021.
The current consensus among 4 TipRanks analysts is for a Moderate Buy rating of shares in Prestige Brand Holdings, with an average price target of $54.5.
The analysts price targets range from a high of $57 to a low of $52.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $237.76 million and a net profit of $70.94 million. The company's market cap is $2.49 billion.
According to TipRanks.com, D.A. Davidson analyst D.A. Davidson is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 16.1% and a 62.04% success rate.
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.